Pioneering Local Drug Delivery
Purgo Scientific is a health science company created for one reason: to bring a medical device to market that targets infection by sustaining local drug delivery in both human and animal health.
Pioneering Local Drug Delivery
Purgo Scientific is a health science company created for one reason: to bring a medical device to market that targets infection by sustaining local drug delivery in both human and animal health.
Leading The Science
Dustin Williams, PhD
Inventor | Co-Founder | Co-Developer | CSO
Helped develop new prosthetic legs for soldiers and Veterans
Lead scientist in research to prevent painful bone pathology after blast-related trauma
Developing technologies to treat and prevent infection in battlefield wounds
Purgo Scientific, a sub-awardee of the grant, formed to make pouch available for everyone suffering from Surgical Site Infection
Conceived Purgo Pouch to solve problem of Surgical Site Infection for Wounded Warriors and trauma patients
Leading The Science
Dustin Williams, PhD
Inventor | Co-Founder | Co-Developer | CSO
Helped develop new prosthetic legs for soldiers and Veterans
Lead reserach to mitigate bone pathologies that affect blast-related trauma patients
Developing technologies to treat and prevent infection in battlefield wounds
Supports Purgo Scientific’s efforts to develop Purgo Pouch for those who suffer from surgical site infections
Leading The Science
Dustin Williams, PhD
Inventor | Co-Founder | Co-Developer | CSO
Helped develop new prosthetic legs for soldiers and Veterans
Lead research to mitigate bone pathologies that affect blast-related trauma patients
Developing technologies to treat and prevent infection in battlefield wounds
Supports Purgo Scientific’s efforts to develop Purgo Pouch for those who suffer from surgical site infections
Purgo Team Members
Management Team
Board Of Directors
Scientific Advisory Board
Advisory Board Members
Business Milestones
- Raised $3,500,000 Series A.3 offering
- Received investment from the Utah Innovation Fund
- Engaged in Sprint Discussions with the FDA
- Engaged CRO for first in-human trials beginning in 2025
- Implemented a Quality Management System
- USPTO issued 2 additional patents for “Therapeutic Delivery Device”
- Soft launched Vetlen Pouch for market entry in October
- Launched Vetlen Pouch into the veterinary market
- Received PRMRP DoD award for $5,460,000
- Received MRDC BBAA award for $3,600,000
- FDA breakthrough device designation
- Prepared strategy and established relationships with surgeons to participate in clinical trials
- Raised an additional $1,050,000 completing the Series A.2 Offering
- Inducted into 2023 MedTech Innovator Accelerator, 1 of 61 companies chosen from 1,900 applicants
- USPTO issued 2 additional patents for “Therapeutic Delivery Device” for a total of 4
- Created Business Advisory Board
- Created Veterinay Advisory Board
- President hired for Vetlen Advanced Veterinary Devices, a Purgo Scientific subsidiary
- $5,460,000 contract awarded by the Department of Defense for continued pouch development
- Began A.3 fundraising round for up to $3,000,000
- Added 1 additional board member
- Commenced FDA clearance process
- Initiated 60+ sheep study
- Filed additional patent applications
- Filed for FDA clearance
- Raised additional funds through grants
- Completed private placement of series A-2. $2MM ROUND
- Prepped for clinical trials
- Pre-submission reviewed with FDA
- Raised an additional $350,000 towards completing the Series A.2 offering
- Successfully completed 138 sheep study with up to 8 log10 bacterial reduction
- Created Scientific Advisory Board
- Appointed new CEO
- Prototype completed using all medical grade components
- Continued sheep studies to confirm efficacy of the pouch
- Raised $600,000 in funding IN SERIES A-2 ROUND
- Filed 5 continuation patents with USPTO
- $4,260,000 in funded grants from the Department of Defense for Purgo Pouch development for Wounded Warriors
- USPTO issued a patent for “Therapeutic Delivery Device”
- Prior to issuance, Purgo filed three patent continuations for new innovations
- Began initial sheep study
- Raised $350,000 of seed capital
- Started developing prototypes
- Developed business plan, implemented IP strategy
- Applied for Department of Defense awards
- Invented by Dustin Williams, PhD Associate Professor, Director of the Bone and Biofilm Research Lab, and Nicholas Ashton, PhD at the University of Utah
- Exclusive License Agreement with University of Utah Research Foundation
- Created Board of Directors
- Raised $3,500,000 Series A.3 offering
- Received investment from the Utah Innovation Fund
- Engaged in Sprint Discussions with the FDA
- Engaged CRO for first in-human trials beginning in 2025
- Implemented a Quality Management System
- USPTO issued 2 additional patents for “Therapeutic Delivery Device”
- Soft launched Vetlen Pouch for market entry in October
- Launched Vetlen Pouch into the veterinary market
- Received PRMRP DoD award for $5,460,000
- Received MRDC BBAA award for $3,600,000
- FDA breakthrough device designation
- Prepared strategy and established relationships with surgeons to participate in clinical trials
- Raised an additional $1,050,000 completing the Series A.2 Offering
- Inducted into 2023 MedTech Innovator Accelerator, 1 of 61 companies chosen from 1,900 applicants
- USPTO issued 2 additional patents for “Therapeutic Delivery Device” for a total of 4
- Created Business Advisory Board
- Created Veterinay Advisory Board
- President hired for Vetlen Advanced Veterinary Devices, a Purgo Scientific subsidiary
- $5,460,000 contract awarded by the Department of Defense for continued pouch development
- Began A.3 fundraising round for up to $3,000,000
- Added 1 additional board member
- Commenced FDA clearance process
- Initiated 60+ sheep study
- Filed additional patent applications
- Filed for FDA clearance
- Raised additional funds through grants
- Completed private placement of series A-2. $2MM ROUND
- Prepped for clinical trials
- Pre-submission reviewed with FDA
- Raised an additional $350,000 towards completing the Series A.2 offering
- Successfully completed 138 sheep study with up to 8 log10 bacterial reduction
- Created Scientific Advisory Board
- Appointed new CEO
- Prototype completed using all medical grade components
- Continued sheep studies to confirm efficacy of the pouch
- Raised $600,000 in funding IN SERIES A-2 ROUND
- Filed 5 continuation patents with USPTO
- $4,260,000 in funded grants from the Department of Defense for Purgo Pouch development for Wounded Warriors
- USPTO issued a patent for “Therapeutic Delivery Device”
- Prior to issuance, Purgo filed three patent continuations for new innovations
- Began initial sheep study
- Raised $350,000 of seed capital
- Started developing prototypes
- Developed business plan, implemented IP strategy
- Applied for Department of Defense awards
- Invented by Dustin Williams, PhD Associate Professor, Director of the Bone and Biofilm Research Lab, and Nicholas Ashton, PhD at the University of Utah
- Exclusive License Agreement with University of Utah Research Foundation
- Created Board of Directors